- Home
- RIOT vs GH Comparison
RIOT vs GH Comparison
Compare RIOT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIOT
- GH
- Stock Information
- Founded
- RIOT 2000
- GH 2011
- Country
- RIOT United States
- GH United States
- Employees
- RIOT N/A
- GH N/A
- Industry
- RIOT Retail: Computer Software & Peripheral Equipment
- GH Medical Specialities
- Sector
- RIOT Technology
- GH Health Care
- Exchange
- RIOT Nasdaq
- GH Nasdaq
- Market Cap
- RIOT 5.9B
- GH 4.9B
- IPO Year
- RIOT N/A
- GH 2018
- Fundamental
- Price
- RIOT $17.54
- GH $58.80
- Analyst Decision
- RIOT Buy
- GH Strong Buy
- Analyst Count
- RIOT 10
- GH 17
- Target Price
- RIOT $17.03
- GH $58.24
- AVG Volume (30 Days)
- RIOT 42.0M
- GH 2.3M
- Earning Date
- RIOT 10-29-2025
- GH 11-05-2025
- Dividend Yield
- RIOT N/A
- GH N/A
- EPS Growth
- RIOT N/A
- GH N/A
- EPS
- RIOT N/A
- GH N/A
- Revenue
- RIOT $541,719,000.00
- GH $828,849,000.00
- Revenue This Year
- RIOT $81.15
- GH $28.07
- Revenue Next Year
- RIOT $23.65
- GH $21.61
- P/E Ratio
- RIOT N/A
- GH N/A
- Revenue Growth
- RIOT 93.46
- GH 28.74
- 52 Week Low
- RIOT $6.19
- GH $20.14
- 52 Week High
- RIOT $18.04
- GH $68.00
- Technical
- Relative Strength Index (RSI)
- RIOT 73.87
- GH 53.29
- Support Level
- RIOT $15.55
- GH $53.40
- Resistance Level
- RIOT $16.83
- GH $61.95
- Average True Range (ATR)
- RIOT 0.99
- GH 2.54
- MACD
- RIOT 0.36
- GH -0.95
- Stochastic Oscillator
- RIOT 91.91
- GH 36.99
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.